Evidence map›Paper›PMID 42324194›Full record

ArticleZhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery2026

[Impact of unplanned surgery on prognosis of myxoid liposarcoma and analysis of salvage treatment strategies].

Guoxin Qu, Jingyu Hou, Qilong Su, Chunlei Zhang, Jiaqiang Wang, Xin Wang, Peng Zhang, Xiaohui Niu, Weitao Yao

Abstract readEnglish Abstract
In one paragraph

Article in Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Guoxin QuDepartment of Bone and Soft Tissue, Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou Henan, 450008, P. R. China.
Jingyu HouDepartment of Bone and Soft Tissue, Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou Henan, 450008, P. R. China.
Qilong SuDepartment of Bone and Soft Tissue, Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou Henan, 450008, P. R. China.
Chunlei ZhangDepartment of Bone and Soft Tissue, Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou Henan, 450008, P. R. China.
Jiaqiang WangDepartment of Bone and Soft Tissue, Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou Henan, 450008, P. R. China.
Xin WangDepartment of Bone and Soft Tissue, Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou Henan, 450008, P. R. China.
Peng ZhangDepartment of Bone and Soft Tissue, Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou Henan, 450008, P. R. China.
Xiaohui NiuDepartment of Osteo-Oncology, Capital Medical University Affiliated Beijing Jishuitan Hospital, Beijing, 100032, P. R. China.
Weitao YaoDepartment of Bone and Soft Tissue, Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou Henan, 450008, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To compare the effectiveness of different treatment strategies after unplanned surgery for myxoid liposarcoma (MLS) and explore the clinical value of salvage therapy versus planned treatment following unplanned resection. Methods: The clinical data of 37 MLS patients admitted between June 2014 and June 2024 who met the selection criteria were retrospectively analyzed. Patients were divided into three groups based on initial treatment status: the unplanned treatment group (group A, 14 cases, transferred after benign tumor excision without further treatment at external hospitals, presenting with local recurrence), the salvage planned treatment group (group B, 10 cases, transferred within 1 month after benign tumor excision at external hospitals), and the planned treatment group (group C, 13 cases, transferred without prior treatment or only after biopsy). No significant difference ( Results: All 37 patients were followed up 19-193 months (mean, 67.4 months). Group A exhibited higher tumor recurrence (28.6%) and metastasis rates (35.7%) than group B (10.0%, 10.0%) and group C (0, 23.1%), with significant differences in recurrence rates ( Conclusion: Patients with MLS should undergo standard extended resection and individualized adjuvant radiotherapy and chemotherapy as soon as possible after unplanned surgery to significantly reduce the local recurrence rate. In view of the high risk of extrapulmonary metastasis, a comprehensive preoperative assessment of metastasis is required.

Indexed as

Liposarcoma, MyxoidSalvage TherapyAdultAgedDisease-Free SurvivalFemaleHumansKaplan-Meier EstimateMaleMiddle AgedNeoplasm Recurrence, LocalPrognosisRetrospective StudiesTreatment Outcomeextended resectionMyxoid liposarcomasoft tissue sarcomaunplanned surgery

Identifiers

PMID42324194
PMCPMC13283925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.